We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
-4.25%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$87.1M
AUM Growth
-$39.1M
Cap. Flow
-$42.6M
Cap. Flow %
-48.9%
Top 10 Hldgs %
44.48%
Holding
450
New
86
Increased
61
Reduced
79
Closed
202

Top Buys

Rank Stock Value
1
STZ icon
Constellation Brands
STZ
+$3.18M
2
JPM icon
JPMorgan Chase
JPM
+$3.16M
3
GIS icon
General Mills
GIS
+$2.29M
4
GILD icon
Gilead Sciences
GILD
+$2.29M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$2M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$4.04M
2
BMY icon
Bristol-Myers Squibb
BMY
+$3.96M
3
CLVS
Clovis Oncology, Inc.
CLVS
+$2.56M
4
IBB icon
iShares Biotechnology ETF
IBB
+$2.03M
5
HUM icon
Humana
HUM
+$1.77M

Sector Composition

Rank Sector Weight
1 Healthcare 44.7%
2 Consumer Staples 14.06%
3 Consumer Discretionary 4.38%
4 Financials 4.11%
5 Communication Services 3.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NXPI icon
226
CALL
NXP Semiconductors
NXPI
$67.3B
$3K ﹤0.01%
30,100
-26,500
-47% -$2.63M
CASC
227
CALL
DELISTED
Cascadian Therapeutics, Inc.
CASC
$3K ﹤0.01%
+10,800
New +$69.8K
CEMP
228
CALL
DELISTED
Cempra, Inc.
CEMP
$3K ﹤0.01%
102,000
+52,400
+106% +$636K
BLUE
229
CALL
DELISTED
bluebird bio
BLUE
$2K ﹤0.01%
1,992
-965
-33% -$766K
CCEP icon
230
PUT
Coca-Cola Europacific Partners
CCEP
$46.5B
$2K ﹤0.01%
400
– –
CRM icon
231
CALL
Salesforce
CRM
$140B
$2K ﹤0.01%
31,400
+27,600
+726% +$2M
LLY icon
232
CALL
Eli Lilly
LLY
$1.05T
$2K ﹤0.01%
60,000
+700
+1% +$52.1K
SBUX icon
233
CALL
Starbucks
SBUX
$120B
$2K ﹤0.01%
75,000
+62,500
+500% +$3.46M
LUMO
234
CALL
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$2K ﹤0.01%
5,611
– –
ISEE
235
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$2K ﹤0.01%
104,400
+49,300
+89% +$1.46M
RDUS
236
CALL
DELISTED
Radius Health, Inc.
RDUS
$2K ﹤0.01%
31,000
+29,500
+1,967% +$1.4M
CRAY
237
CALL
DELISTED
Cray, Inc.
CRAY
$2K ﹤0.01%
+7,600
New +$156K
ARWR icon
238
CALL
Arrowhead Research
ARWR
$10.5B
$1K ﹤0.01%
105,500
+16,700
+19% +$71.1K
BBY icon
239
CALL
Best Buy
BBY
$18B
$1K ﹤0.01%
+10,000
New +$425K
BHC icon
240
CALL
Bausch Health
BHC
$1.8B
$1K ﹤0.01%
22,500
-18,900
-46% -$347K
BLUE
241
PUT
DELISTED
bluebird bio
BLUE
$1K ﹤0.01%
826
-772
-48% -$613K
CCEP icon
242
CALL
Coca-Cola Europacific Partners
CCEP
$46.5B
$1K ﹤0.01%
30,100
-34,100
-53% -$1.2M
KMB icon
243
CALL
Kimberly-Clark
KMB
$36B
$1K ﹤0.01%
2,300
-153,600
-99% -$17.8M
MNK
244
CALL
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$1K ﹤0.01%
11,500
– –
CEMP
245
DELISTED
Cempra, Inc.
CEMP
$1K ﹤0.01%
+200
New +$2.43K
CEMP
246
PUT
DELISTED
Cempra, Inc.
CEMP
$1K ﹤0.01%
+200
New +$2.43K
AAPL icon
247
CALL
Apple
AAPL
$4.9T
– –
-194,400
Closed -$691K
AAPL icon
248
Apple
AAPL
$4.9T
– –
-11,684
Closed -$330K
AAPL icon
249
PUT
Apple
AAPL
$4.9T
– –
-174,400
Closed -$105K
ACN icon
250
CALL
Accenture
ACN
$87.9B
– –
-8,900
Closed -$74K
8 9
10
11 12

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q4 2016 Portfolio in Review

As of Q4 2016, FT Options held 450 positions worth $87.1M, down 31% from $126M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

FT Options withdrew a net $42.6M in Q4 2016, closing 202 positions and reducing 79 holdings. Its most notable exit was Procter & Gamble, an estimated $4.04M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 40% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, FT Options opened a new position in Constellation Brands worth $3.07M.

  • FT Options's largest Q4 2016 buy was Constellation Brands: 20,000 shares worth $3.07M.
  • FT Options added most to General Mills in Q4 2016, an estimated $2.29M increase.
  • FT Options's biggest Q4 2016 reduction was Monsanto Co, cutting an estimated $1.06M.
  • FT Options fully exited Procter & Gamble in Q4 2016, selling an estimated $4.04M.
  • FT Options's ten largest holdings make up 44% of its $87.1M portfolio in Q4 2016.
  • FT Options opened 86 new positions and closed 202 in Q4 2016.
  • FT Options's portfolio value fell 31% quarter-over-quarter to $87.1M.

Based on FT Options's 13F filing for Q4 2016, filed 10 Feb 2017.